
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Zap-70 CRISPR/Cas9 KO Plasmid (m) | sc-423755 | 20 µg | $397.00 |
Zap70 encodes the cytosolic tyrosine kinase ZAP-70, a core signaling mediator downstream of the T cell receptor (TCR) and CD3 complex that links antigen recognition to intracellular phosphorylation cascades. Upon TCR engagement, ZAP-70 is recruited to phosphorylated ITAMs on CD3 chains and propagates signaling through LAT/SLP-76 scaffolding, driving PLCγ1 activation, calcium flux, MAPK signaling, and NFAT/NF-κB/AP-1 transcriptional programs. In mouse immune biology, Zap70 is essential for thymocyte selection, T cell maturation, and effector responses, making it central to studies of adaptive immunity and lymphocyte signaling networks. Dysregulated ZAP-70 pathway activity is relevant to models of immunodeficiency, autoimmunity, and lymphoid malignancy biology, where altered signaling thresholds influence development and activation.
Zap-70 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Zap70 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Zap70 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Zap70 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Zap-70 protein expression.
This CRISPR knockout system enables efficient generation of Zap70-deficient cell models for investigation of Zap-70 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.